Skip to main content
مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
Cart
Lists
Your lists
Log in to create your own lists
Log in to your account
Your cookies
Search history
Search the catalog by:
Library catalog
Title
Author
Subject
ISBN
ISSN
Series
Call number
Search the catalog by keyword
Advanced search
Authority search
Tag cloud
Library
Log in to your account
Home
Advanced search
Results of search for 'au:"Ligueros-Saylan, M"'
Refine your search
Availability
Limit to records with available items
Authors
Balez, S
Bullock, J
Campestrini, J
Couturier, A
Deacon, C F
Dejager, S
Devineni, D
Dilzer, S C
Dole, W P
Dunning, B E
Foley, J E
He, Y-L
Holst, J J
Jarugula, V
Kothny, W
Ligueros-Saylan, M
Schweizer, A
Serra, D
Wang, Y
Zhang, Y
Show more
Show less
Topics
Adamantane
Adolescent
Adult
Aged
Area Under Curve
Cross-Over Studies
Diabetes Mellitus, Type 2
Dipeptidyl-Peptidase IV Inhibitors
Female
Humans
Hypoglycemic Agents
Insulin
Male
Middle Aged
Nitriles
Pyrrolidines
Vildagliptin
administration & dosage
drug effects
drug therapy
Show more
Show less
Languages
English
Your search returned 9 results.
Sort
Sort by:
Relevance
Popularity (most to least)
Popularity (least to most)
Author (A-Z)
Author (Z-A)
Call number (0-9 to A-Z)
Call number (Z-A to 9-0)
Publication/Copyright date: Newest to oldest
Publication/Copyright date: Oldest to newest
Acquisition date: Newest to oldest
Acquisition date: Oldest to newest
Title (A-Z)
Title (Z-A)
Unhighlight
Highlight
Select all
Clear all
Select titles to:
Add to cart
Add to list
New list
Place hold
Results
1.
An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials.
[electronic resource]
by
Ligueros-Saylan, M
Foley, J E
Schweizer, A
Couturier, A
Kothny, W
Producer:
20110603
In:
Diabetes, obesity & metabolism
vol. 12
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
2.
Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population.
[electronic resource]
by
Schweizer, A
Dejager, S
Foley, J E
Couturier, A
Ligueros-Saylan, M
Kothny, W
Producer:
20110603
In:
Diabetes, obesity & metabolism
vol. 12
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
3.
Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
[electronic resource]
by
He, Y-L
Zhang, Y
Serra, D
Wang, Y
Ligueros-Saylan, M
Dole, W P
Producer:
20111101
In:
Current medical research and opinion
vol. 27
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
4.
Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects.
[electronic resource]
by
He, Y-L
Paladini, S
Sabia, H
Campestrini, J
Zhang, Y
Leon, S
Ligueros-Saylan, M
Jarugula, V
Producer:
20080818
In:
International journal of clinical pharmacology and therapeutics
vol. 46
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
5.
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin.
[electronic resource]
by
He, Y-L
Sabo, R
Campestrini, J
Wang, Y
Ligueros-Saylan, M
Lasseter, K C
Dilzer, S C
Howard, D
Dole, W P
Producer:
20071203
In:
European journal of clinical pharmacology
vol. 63
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
6.
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.
[electronic resource]
by
Serra, D
He, Y-L
Bullock, J
Riviere, G-J
Balez, S
Schwartz, S
Wang, Y
Ligueros-Saylan, M
Jarugula, V
Dole, W P
Producer:
20081007
In:
International journal of clinical pharmacology and therapeutics
vol. 46
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
7.
Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus.
[electronic resource]
by
Kahn, S E
Montgomery, B
Howell, W
Ligueros-Saylan, M
Hsu, C H
Devineni, D
McLeod, J F
Horowitz, A
Foley, J E
Producer:
20011228
In:
The Journal of clinical endocrinology and metabolism
vol. 86
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
8.
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes.
[electronic resource]
by
Mari, A
Sallas, W M
He, Y L
Watson, C
Ligueros-Saylan, M
Dunning, B E
Deacon, C F
Holst, J J
Foley, J E
Producer:
20050914
In:
The Journal of clinical endocrinology and metabolism
vol. 90
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)
9.
Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes.
[electronic resource]
by
Foley, J E
Ligueros-Saylan, M
He, Y-L
Holst, J J
Deacon, C F
Dunning, B E
Leone-Jones, A
Yu, T
Kelley, D E
Producer:
20081114
In:
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
vol. 40
Online resources:
Available from publisher's website
Availability:
No items available.
Save to lists
Add to cart
(remove)